Literature DB >> 6171128

Relationships between metabolic and hemostatic variables in uncomplicated diabetes.

C Vergani, G Bettale, D Mari, P M Mannucci.   

Abstract

Several metabolic (HbA1, HDL-C, triglycerides) and hemostatic (VIIIR: Ag, VIII:C, B-TG variables were investigated in 35 non-obese, insulin-dependent diabetics without clinically evident vascular complications. B-TG was high but did not correlate with other metabolic and hemostatic parameters, suggesting that elevated B-TG in diabetes might be an expression of in vitro platelet activation. VIIIR: Ag and the ratio of VIIIR: Ag to VIII: C were markedly increased. There was a significant correlation of the HbA1 and HDL-C levels with VIIIR: Ag, indicating that VIIIR:Ag is another reflection of metabolic control in diabetes. Additional pathogenic mechanisms, however, appear to be involved in causing the changes in VIIIR: Ag in diabetes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171128     DOI: 10.1007/BF02047890

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  34 in total

1.  [On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins].

Authors:  M BURSTEIN; J SAMAILLE
Journal:  Clin Chim Acta       Date:  1960-07       Impact factor: 3.786

2.  Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man.

Authors:  E A Nikkilä; M R Taskinen; M Kekki
Journal:  Atherosclerosis       Date:  1978-04       Impact factor: 5.162

3.  Relation between growth hormone levels and Von Willebrand factor activity.

Authors:  K E Sarji; J H Levine; R M Nair; J Sagel; J A Colwell
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

Review 4.  Platelet function in diabetes mellitus.

Authors:  J A Colwell; P V Halushka
Journal:  Br J Haematol       Date:  1980-04       Impact factor: 6.998

5.  Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIIIR:WF) in diabetes mellitus.

Authors:  J Gonzalez; J A Colwell; K E Sarji; R M Nair; J Sagel
Journal:  Thromb Res       Date:  1980 Jan 1-15       Impact factor: 3.944

6.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

7.  Serum total lipids, lipoproteins cholesterol, apoproteins A and B in cardiovascular disease.

Authors:  C Vergani; G Trovato; N Dioguardi
Journal:  Clin Chim Acta       Date:  1978-07-01       Impact factor: 3.786

8.  Significance of increased factor VIII in early glomerulonephritis.

Authors:  M R Ekberg; I M Nilsson; F Linell
Journal:  Ann Intern Med       Date:  1975-09       Impact factor: 25.391

9.  Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus.

Authors:  G D Calvert; J J Graham; T Mannik; P H Wise; R A Yeates
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

10.  Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy.

Authors:  F E Preston; J D Ward; B H Marcola; N R Porter; W R Timperley; B C O'Malley
Journal:  Lancet       Date:  1978-02-04       Impact factor: 79.321

View more
  1 in total

1.  Factor VIII Level is Not Modifiable by Improved Glycemic Control in Patients with Ischemic Stroke.

Authors:  Alyana A Samai; Amelia K Boehme; Alexander George; Laurie Schluter; Ramy El Khoury; Sheryl Martin-Schild
Journal:  Sci Times J Diabetes       Date:  2017-03-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.